| Reference | FOI2026/1856 |
|---|---|
| Description | Treatment of Immune thrombocytopenia (ITP) |
| Date Requested | 29/06/2026 |
| Date Replied | 09/07/2026 |
| Category | Medicines Optimisation |
| Does NHS Greater Manchester ICB have any local guidelines/protocols for the treatment of Immune thrombocytopenia (ITP)? | Yes |
| If yes, please provide a copy. |
At present, the only guidance available through GMMMG is a recommendation statement for rituximab as a treatment option for immune thrombocytopenia (ITP): GMMMG-Rituximab-recommendation-final.pdf
An ITP treatment pathway is currently in development under GMMMG’s subgroup.
